Cargando…
Progress in research on paclitaxel and tumor immunotherapy
Paclitaxel is a well-known anticancer agent with a unique mechanism of action. It is considered to be one of the most successful natural anticancer drugs available. This study summarizes the recent advances in our understanding of the sources, the anticancer mechanism, and the biosynthetic pathway o...
Autores principales: | Zhu, Linyan, Chen, Liqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567594/ https://www.ncbi.nlm.nih.gov/pubmed/31223315 http://dx.doi.org/10.1186/s11658-019-0164-y |
Ejemplares similares
-
Research progress of nanovaccine in anti-tumor immunotherapy
por: Yao, Min, et al.
Publicado: (2023) -
Research Progress of Immunotherapy for Gastric Cancer
por: Zhang, Zhipeng, et al.
Publicado: (2023) -
Role of ferroptosis on tumor progression and immunotherapy
por: Gong, Deting, et al.
Publicado: (2022) -
Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023) -
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
por: Tu, Jingyao, et al.
Publicado: (2023)